{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:33:00Z","timestamp":1775914380870,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,12]]},"abstract":"<jats:p>Irritable bowel syndrome (IBS) is a common pediatric functional gastrointestinal disorder. It is characterized by recurrent abdominal pain and changes in bowel habits and is more prevalent in obese patients. We investigated the association between obesity and IBS in pediatric patients through fecal calprotectin testing.<\/jats:p>\n          <jats:p>Patients under 18 years of age with IBS who underwent fecal calprotectin testing from January 2015 through April 2020 were retrospectively investigated. The patients were divided into groups based on body mass index (BMI): group I (BMI &lt; 85th percentile) and group II (BMI \u2265 85th percentile). Group II was divided into group IIa, overweight (85th percentile \u2264 BMI &lt; 95th percentile), and group IIb, obese (BMI \u2265 95th percentile).<\/jats:p>\n          <jats:p>Among 277 included patients, 202 (72.9%) were in group I, and 75 (27.1%) were in group II (mean calprotectin levels, 75.60\u2009\u00b1\u2009103.48 vs 45.89\u2009\u00b1\u200966.57 \u00b5g\/g, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = .006). There were significant differences in mean calprotectin levels between groups I and IIa (75.60\u2009\u00b1\u2009103.48 vs 45.45\u2009\u00b1\u200963.38 \u00b5g\/g, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = .028) and groups I and IIb (75.60\u2009\u00b1\u2009103.48 vs 46.22\u2009\u00b1\u200969.59 \u00b5g\/g, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = .025). There was a significant difference in mean calprotectin levels between groups I and II (85.69\u2009\u00b1\u2009142.13 vs 32.04\u2009\u00b1\u200928.17 \u00b5g\/g, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = .029) among patients between 6 and 12 years of age but not among adolescents aged between 12 and 18 years (<jats:italic toggle=\"yes\">P<\/jats:italic> = .139). Fecal calprotectin was lower when moderate-to-severe fatty livers were observed by ultrasound compared with normal livers (68.52\u2009\u00b1\u200997.22 vs 18.53\u2009\u00b1\u200918.56 \u00b5g\/g, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = .017).<\/jats:p>\n          <jats:p>Fecal calprotectin levels were higher in normal-weight pediatric IBS patients than in their obese counterparts, and this difference was more prominent in younger patients. In young children, IBS symptoms are thought to be influenced more by factors other than intestinal inflammation.<\/jats:p>","DOI":"10.1097\/md.0000000000029968","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T14:07:28Z","timestamp":1660313248000},"page":"e29968","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome"],"prefix":"10.1097","volume":"101","author":[{"given":"Jun Hwan","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea"},{"name":"College of Medicine, Chung-Ang University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Yong","family":"Yi","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea"},{"name":"College of Medicine, Chung-Ang University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Min","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Soonchunhyang University College of Medicine, Bucheon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You Jin","family":"Choi","sequence":"additional","affiliation":[{"name":"College of Medicine, Chung-Ang University, Seoul, Korea"},{"name":"Department of Pediatrics, Ilsan Paik Hospital, Inje University College of Medicine, Ilsan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Eulji University Hospital, Daejeon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Hee","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Soonchunhyang University College of Medicine, Bucheon, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Young","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Yeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na Mi","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea"},{"name":"College of Medicine, Chung-Ang University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin Weon","family":"Yun","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea"},{"name":"College of Medicine, Chung-Ang University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Ahn","family":"Chae","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea"},{"name":"College of Medicine, Chung-Ang University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Seok","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea"},{"name":"College of Medicine, Chung-Ang University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eung Sang","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hanil General Hospital, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Sook","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chung-Ang University Gwangmyeong Hospital Gwangmyeong, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders.","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5056\/jnm16214","article-title":"What is new in Rome IV.","volume":"23","author":"Schmulson","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/MPG.0000000000000714","article-title":"Epidemiology of irritable bowel syndrome in children and adolescents in Asia.","volume":"60","author":"Devanarayana","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3748\/wjg.v24.i21.2211","article-title":"Irritable bowel syndrome in children: current knowledge, challenges and opportunities.","volume":"24","author":"Devanarayana","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijnurstu.2008.07.006","article-title":"Prevalence and risk factors of irritable bowel syndrome in Korean adolescent girls: a school-based study.","volume":"46","author":"Son","year":"2009","journal-title":"Int J Nurs Stud"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","article-title":"Intestinal microbiota in functional bowel disorders: a Rome foundation report.","volume":"62","author":"Simr\u00e9n","year":"2013","journal-title":"Gut"},{"key":"R7-20250504","first-page":"8886","article-title":"Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-0897-4_6","article-title":"The brain-gut axis in health and disease.","volume":"817","author":"Al Omran","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"R9-20250504","first-page":"8859","article-title":"Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.","volume":"20","author":"Hyland","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5217\/ir.2016.14.4.297","article-title":"Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place.","volume":"14","author":"Abdul Rani","year":"2016","journal-title":"Intest Res"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s42000-019-00113-9","article-title":"Irritable bowel syndrome: a new therapeutic target when treating obesity?","volume":"18","author":"Pugliese","year":"2019","journal-title":"Hormones"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ijo.2014.67","article-title":"Prevalence of functional gastrointestinal disorders in obese and overweight children.","volume":"38","author":"Phatak","year":"2014","journal-title":"Int J Obes"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MPG.0000000000002208","article-title":"Association between obesity\/overweight and functional gastrointestinal disorders in children.","volume":"68","author":"Tambucci","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12887-020-02106-9","article-title":"Higher prevalence of obesity among children with functional abdominal pain disorders.","volume":"20","author":"Galai","year":"2020","journal-title":"BMC Pediatr"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5223\/pghn.2017.20.2.71","article-title":"Nutritional counseling for obese children with obesity-related metabolic abnormalities in Korea.","volume":"20","author":"Kang","year":"2017","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5223\/pghn.2019.22.1.1","article-title":"Clinical practice guidelines for the diagnosis and treatment of pediatric obesity: recommendations from the Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology, Hepatology, and Nutrition.","volume":"22","author":"Yi","year":"2019","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1542\/peds.2012-0055I","article-title":"Standard 6: age groups for pediatric trials.","volume":"129","author":"Williams","year":"2012","journal-title":"Pediatrics"},{"key":"R19-20250504","first-page":"689","article-title":"Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease.","volume":"99","author":"Bonn\u00edn","year":"2007","journal-title":"Rev Esp Enferm Dig"},{"key":"R20-20250504","first-page":"69","article-title":"Pediatrics. Fecal calprotectin in children: use and interpretation.","volume":"7","author":"Ezri","year":"2011","journal-title":"Rev Med Suisse"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4321\/S1130-01082007001200001","article-title":"Fecal calprotectin.","volume":"99","author":"Rodrigo","year":"2007","journal-title":"Rev Esp Enferm Dig"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5223\/pghn.2018.21.3.189","article-title":"Amino acid-based formula in premature infants with feeding intolerance: comparison of fecal calprotectin levels.","volume":"21","author":"Jang","year":"2018","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3345\/kjp.2019.00115","article-title":"Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients.","volume":"62","author":"Kim","year":"2019","journal-title":"Korean J Pediatr"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3109\/00365521.2014.920915","article-title":"Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small bowel Crohn\u2019s disease.","volume":"49","author":"H\u00f6\u00f6g","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/00365521.2014.1003395","article-title":"Fecal calprotectin in patients with suspected small bowel disease\u2014a selection tool for small bowel capsule endoscopy?","volume":"50","author":"Olsen","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"R26-20250504","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2126","article-title":"Noninvasive tests for inflammatory bowel disease: a meta-analysis.","volume":"137","author":"Holtman","year":"2016","journal-title":"Pediatrics"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis.","volume":"341","author":"van Rheenen","year":"2010","journal-title":"BMJ"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12887-020-02263-x","article-title":"Fecal calprotectin as a marker of gastrointestinal involvement in pediatric Henoch-Sch\u00f6nlein purpura patients: a retrospective analysis.","volume":"20","author":"Paek","year":"2020","journal-title":"BMC Pediatr"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3345\/kjp.2019.00059","article-title":"The role of fecal calprotectin in pediatric disease.","volume":"62","author":"Jeong","year":"2019","journal-title":"Korean J Pediatr"},{"key":"R30-20250504","first-page":"4095789","article-title":"The gut microbiome profile in obesity: a systematic review.","volume":"2018","author":"Castaner","year":"2018","journal-title":"Int J Endocrinol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications.","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch Med Sci"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5217\/ir.2019.00009","article-title":"Is fecal calprotectin always normal in children with irritable bowel syndrome?","volume":"17","author":"Choi","year":"2019","journal-title":"Intest Res"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3748\/wjg.v24.i21.2211","article-title":"Irritable bowel syndrome in children: current knowledge, challenges and opportunities.","volume":"24","author":"Devanarayana","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/ATVBAHA.111.228262","article-title":"Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation.","volume":"31","author":"Ndumele","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajg.2020.09.003","article-title":"Association of obesity and non-alcoholic fatty liver disease with the fecal calprotectin level in children.","volume":"21","author":"Demirba\u015f","year":"2020","journal-title":"Arab J Gastroenterol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7570\/jomes.2018.27.4.233","article-title":"A study of fecal calprotectin in obese children and adults.","volume":"27","author":"Park","year":"2018","journal-title":"J Obes Metab Syndr"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1002\/jcp.26791","article-title":"Serum C-reactive protein in the prediction of cardiovascular diseases: overview of the latest clinical studies and public health practice.","volume":"233","author":"Avan","year":"2018","journal-title":"J Cell Physiol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults.","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:00:31Z","timestamp":1746334831000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":37,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029968","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]}}}